Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial
- 30 November 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 49 (5) , 801-815
- https://doi.org/10.1016/s0190-9622(03)01475-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Unilesional cutaneous T-cell lymphoma: Clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variantJournal of the American Academy of Dermatology, 2000
- Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment RecommendationsJournal of the American Academy of Dermatology, 1997
- Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective RetinoidsJournal of Medicinal Chemistry, 1994
- Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoidesJournal of the American Academy of Dermatology, 1994
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patientsJournal of the American Academy of Dermatology, 1990
- Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989
- Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoidesJournal of the American Academy of Dermatology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958